Evaluating the pharmacokinetics of understudied drugs in children

Description:
Currently, only 25% of drugs approved for use in the United States by the FDA have enough pediatric data to establish safety and efficacy for use in children. This lack of data places children at risk for developing adverse events or ineffective treatments. This study looks to gather data on drugs being used in children that lack sufficient data.

Medication Under Study:
Various

Full study title:
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care

IRB Study ID:
110610


Who may qualify:

Any pediatric patient taking a medication that qualifies for the study

Who does not qualify:

Anyone who is pregnant or not taking medications listed in the study

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774


Lead Principal Investigator:

Photo
Michael Reed, PharmD, FCCP, FCP
Director, Rebecca D. Considine Research Institute
Director, Division of Pharmacology and Toxicology


Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us

    330-543-5012

    E-mail

    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.